Strategic Advisory for Entry and Expansion Across European & International Markets
Oak & Wattle is a boutique advisory firm with extensive expertise in navigating the fragmented regulatory landscape and multi-billion Euro funding ecosystem of the European Union and international markets. Our team, comprised of professionals from KPMG and EY, excels in market entry, grant & capital procurement, and strategic M&A advisory for Healthcare, Pharma, and Tech sectors. We are dedicated to delivering tailored solutions that drive sustainable growth and success.
We design comprehensive commercial roadmaps and ensure regulatory compliance, allowing Healthcare, Pharma, and Tech firms to smoothly enter and expand across the European Union and international markets.
Our direct advisory services for multi-million Euro grant programs, including Horizon Europe, the Innovative Health Initiative, and the Digital Europe Programme, empower firms to secure vital funding.
We provide comprehensive support for buy-side and sell-side M&A transactions and capital raising. Our team manages outreach, negotiations, due diligence, and the complexities of closing deals.
Our expertise in succession planning and business restructuring supports organizations in navigating change, ensuring continuity while enhancing overall business value.
John is a serial entrepreneur and an expert in international trade, market entry, government funding and regulatory compliance. He has lead development & market launch initiatives for medical innovations and has deep experience in marketing and public relations. He is an accomplished M&A and capital raising advisor.
Lanning is a seasoned Chartered Accountant, who began his career at KPMG and EY where he developed a strong foundation in Strategy, Finance, Operations & M&A. He has played pivotal roles in supporting complex acquisitions, divestments, and restructuring across Healthcare, Pharma, Tech, Mining, and Construction.